Report Detail

Request for Sample of this report

Pharma & Healthcare Global Medications for Chronic Pain Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4743976
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 126 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medications for Chronic Pain Treatment market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Medications for chronic pain treatment are pharmaceutical drugs prescribed by healthcare professionals to manage persistent and long-lasting pain conditions. Chronic pain is often defined as pain that persists for three months or longer and can result from various underlying causes, including injury, illness, or medical conditions. The goal of chronic pain medication is to alleviate pain, improve the patient"s quality of life, and enhance their ability to function.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Medications for Chronic Pain Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medications for Chronic Pain Treatment market size and forecasts, in consumption value ($ Million), 2021-2032
Global Medications for Chronic Pain Treatment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Medications for Chronic Pain Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Medications for Chronic Pain Treatment market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medications for Chronic Pain Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medications for Chronic Pain Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Abbott Laboratories, Novartis AG, Johnson and Johnson Services Inc., YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD., BAYER, Jiangsu Hengrui Medicine Co,.Ltd, REYOUNG, Southwest Pharmaceutical Co., Ltd., Depomed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Medications for Chronic Pain Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Nonopioid
Opioids
Market segment by Application
Hospital
Pharmacy
Other
Market segment by players, this report covers
Pfizer
Abbott Laboratories
Novartis AG
Johnson and Johnson Services Inc.
YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
BAYER
Jiangsu Hengrui Medicine Co,.Ltd
REYOUNG
Southwest Pharmaceutical Co., Ltd.
Depomed
Endo International plc.
Purdue Pharma L.P.
AstraZeneca plc.
Merck & Co.
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Medications for Chronic Pain Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Medications for Chronic Pain Treatment, with revenue, gross margin, and global market share of Medications for Chronic Pain Treatment from 2021 to 2026.
Chapter 3, the Medications for Chronic Pain Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Medications for Chronic Pain Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Medications for Chronic Pain Treatment.
Chapter 13, to describe Medications for Chronic Pain Treatment research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Medications for Chronic Pain Treatment by Type
    • 1.3.1 Overview: Global Medications for Chronic Pain Treatment Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Medications for Chronic Pain Treatment Consumption Value Market Share by Type in 2025
    • 1.3.3 Nonopioid
    • 1.3.4 Opioids
  • 1.4 Global Medications for Chronic Pain Treatment Market by Application
    • 1.4.1 Overview: Global Medications for Chronic Pain Treatment Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Pharmacy
    • 1.4.4 Other
  • 1.5 Global Medications for Chronic Pain Treatment Market Size & Forecast
  • 1.6 Global Medications for Chronic Pain Treatment Market Size and Forecast by Region
    • 1.6.1 Global Medications for Chronic Pain Treatment Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Medications for Chronic Pain Treatment Market Size by Region, (2021-2032)
    • 1.6.3 North America Medications for Chronic Pain Treatment Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Medications for Chronic Pain Treatment Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Medications for Chronic Pain Treatment Market Size and Prospect (2021-2032)
    • 1.6.6 South America Medications for Chronic Pain Treatment Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Medications for Chronic Pain Treatment Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Medications for Chronic Pain Treatment Product and Solutions
    • 2.1.4 Pfizer Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments and Future Plans
  • 2.2 Abbott Laboratories
    • 2.2.1 Abbott Laboratories Details
    • 2.2.2 Abbott Laboratories Major Business
    • 2.2.3 Abbott Laboratories Medications for Chronic Pain Treatment Product and Solutions
    • 2.2.4 Abbott Laboratories Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.3 Novartis AG
    • 2.3.1 Novartis AG Details
    • 2.3.2 Novartis AG Major Business
    • 2.3.3 Novartis AG Medications for Chronic Pain Treatment Product and Solutions
    • 2.3.4 Novartis AG Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novartis AG Recent Developments and Future Plans
  • 2.4 Johnson and Johnson Services Inc.
    • 2.4.1 Johnson and Johnson Services Inc. Details
    • 2.4.2 Johnson and Johnson Services Inc. Major Business
    • 2.4.3 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Product and Solutions
    • 2.4.4 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Johnson and Johnson Services Inc. Recent Developments and Future Plans
  • 2.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
    • 2.5.1 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Details
    • 2.5.2 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Major Business
    • 2.5.3 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Product and Solutions
    • 2.5.4 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Recent Developments and Future Plans
  • 2.6 BAYER
    • 2.6.1 BAYER Details
    • 2.6.2 BAYER Major Business
    • 2.6.3 BAYER Medications for Chronic Pain Treatment Product and Solutions
    • 2.6.4 BAYER Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BAYER Recent Developments and Future Plans
  • 2.7 Jiangsu Hengrui Medicine Co,.Ltd
    • 2.7.1 Jiangsu Hengrui Medicine Co,.Ltd Details
    • 2.7.2 Jiangsu Hengrui Medicine Co,.Ltd Major Business
    • 2.7.3 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Product and Solutions
    • 2.7.4 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Jiangsu Hengrui Medicine Co,.Ltd Recent Developments and Future Plans
  • 2.8 REYOUNG
    • 2.8.1 REYOUNG Details
    • 2.8.2 REYOUNG Major Business
    • 2.8.3 REYOUNG Medications for Chronic Pain Treatment Product and Solutions
    • 2.8.4 REYOUNG Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 REYOUNG Recent Developments and Future Plans
  • 2.9 Southwest Pharmaceutical Co., Ltd.
    • 2.9.1 Southwest Pharmaceutical Co., Ltd. Details
    • 2.9.2 Southwest Pharmaceutical Co., Ltd. Major Business
    • 2.9.3 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Product and Solutions
    • 2.9.4 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Southwest Pharmaceutical Co., Ltd. Recent Developments and Future Plans
  • 2.10 Depomed
    • 2.10.1 Depomed Details
    • 2.10.2 Depomed Major Business
    • 2.10.3 Depomed Medications for Chronic Pain Treatment Product and Solutions
    • 2.10.4 Depomed Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Depomed Recent Developments and Future Plans
  • 2.11 Endo International plc.
    • 2.11.1 Endo International plc. Details
    • 2.11.2 Endo International plc. Major Business
    • 2.11.3 Endo International plc. Medications for Chronic Pain Treatment Product and Solutions
    • 2.11.4 Endo International plc. Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Endo International plc. Recent Developments and Future Plans
  • 2.12 Purdue Pharma L.P.
    • 2.12.1 Purdue Pharma L.P. Details
    • 2.12.2 Purdue Pharma L.P. Major Business
    • 2.12.3 Purdue Pharma L.P. Medications for Chronic Pain Treatment Product and Solutions
    • 2.12.4 Purdue Pharma L.P. Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Purdue Pharma L.P. Recent Developments and Future Plans
  • 2.13 AstraZeneca plc.
    • 2.13.1 AstraZeneca plc. Details
    • 2.13.2 AstraZeneca plc. Major Business
    • 2.13.3 AstraZeneca plc. Medications for Chronic Pain Treatment Product and Solutions
    • 2.13.4 AstraZeneca plc. Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 AstraZeneca plc. Recent Developments and Future Plans
  • 2.14 Merck & Co.
    • 2.14.1 Merck & Co. Details
    • 2.14.2 Merck & Co. Major Business
    • 2.14.3 Merck & Co. Medications for Chronic Pain Treatment Product and Solutions
    • 2.14.4 Merck & Co. Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Merck & Co. Recent Developments and Future Plans
  • 2.15 GlaxoSmithKline plc.
    • 2.15.1 GlaxoSmithKline plc. Details
    • 2.15.2 GlaxoSmithKline plc. Major Business
    • 2.15.3 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Product and Solutions
    • 2.15.4 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 GlaxoSmithKline plc. Recent Developments and Future Plans
  • 2.16 Teva Pharmaceutical Industries Ltd.
    • 2.16.1 Teva Pharmaceutical Industries Ltd. Details
    • 2.16.2 Teva Pharmaceutical Industries Ltd. Major Business
    • 2.16.3 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Product and Solutions
    • 2.16.4 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Medications for Chronic Pain Treatment Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Medications for Chronic Pain Treatment by Company Revenue
    • 3.2.2 Top 3 Medications for Chronic Pain Treatment Players Market Share in 2025
    • 3.2.3 Top 6 Medications for Chronic Pain Treatment Players Market Share in 2025
  • 3.3 Medications for Chronic Pain Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Medications for Chronic Pain Treatment Market: Region Footprint
    • 3.3.2 Medications for Chronic Pain Treatment Market: Company Product Type Footprint
    • 3.3.3 Medications for Chronic Pain Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Medications for Chronic Pain Treatment Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Medications for Chronic Pain Treatment Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Medications for Chronic Pain Treatment Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Medications for Chronic Pain Treatment Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Medications for Chronic Pain Treatment Consumption Value by Type (2021-2032)
  • 6.2 North America Medications for Chronic Pain Treatment Market Size by Application (2021-2032)
  • 6.3 North America Medications for Chronic Pain Treatment Market Size by Country
    • 6.3.1 North America Medications for Chronic Pain Treatment Consumption Value by Country (2021-2032)
    • 6.3.2 United States Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Medications for Chronic Pain Treatment Consumption Value by Type (2021-2032)
  • 7.2 Europe Medications for Chronic Pain Treatment Consumption Value by Application (2021-2032)
  • 7.3 Europe Medications for Chronic Pain Treatment Market Size by Country
    • 7.3.1 Europe Medications for Chronic Pain Treatment Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 7.3.3 France Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Medications for Chronic Pain Treatment Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Medications for Chronic Pain Treatment Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Medications for Chronic Pain Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Medications for Chronic Pain Treatment Consumption Value by Region (2021-2032)
    • 8.3.2 China Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 8.3.5 India Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Medications for Chronic Pain Treatment Consumption Value by Type (2021-2032)
  • 9.2 South America Medications for Chronic Pain Treatment Consumption Value by Application (2021-2032)
  • 9.3 South America Medications for Chronic Pain Treatment Market Size by Country
    • 9.3.1 South America Medications for Chronic Pain Treatment Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Medications for Chronic Pain Treatment Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Medications for Chronic Pain Treatment Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Medications for Chronic Pain Treatment Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Medications for Chronic Pain Treatment Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Medications for Chronic Pain Treatment Market Drivers
  • 11.2 Medications for Chronic Pain Treatment Market Restraints
  • 11.3 Medications for Chronic Pain Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Medications for Chronic Pain Treatment Industry Chain
  • 12.2 Medications for Chronic Pain Treatment Upstream Analysis
  • 12.3 Medications for Chronic Pain Treatment Midstream Analysis
  • 12.4 Medications for Chronic Pain Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medications for Chronic Pain Treatment. Industry analysis & Market Report on Medications for Chronic Pain Treatment is a syndicated market report, published as Global Medications for Chronic Pain Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medications for Chronic Pain Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo